Literature DB >> 12514329

SR144528 as inverse agonist of CB2 cannabinoid receptor.

Man-Hee Rhee1, Sang-Keun Kim.   

Abstract

It is now well established that several G protein- coupled receptors can signal without agonist stimulation (constitutive receptors). Inverse agonists have been shown to inhibit the activity of such constitutive G protein-coupled receptor signaling. Agonist activation of the G(i/o)-coupled peripheral cannabinoid receptor CB2 normally inhibits adenylyl cyclase type V and stimulates adenylyl cyclase type II. Using transfected COS cells, we show here that application of SR144528, an inverse agonist of CB2, leads to a reverse action (stimulation of adenylyl cyclase V and inhibition of adenylyl cyclase II). This inverse agonism of SR144528 is dependent on the temperature, as well as on the concentration of the cDNA of CB2 transfected. Pertussis toxin blocked the regulation of adenylyl cyclase activity by SR 144528.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12514329

Source DB:  PubMed          Journal:  J Vet Sci        ISSN: 1229-845X            Impact factor:   1.672


  13 in total

Review 1.  Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

Authors:  William E Greineisen; Helen Turner
Journal:  Int Immunopharmacol       Date:  2010-02-25       Impact factor: 4.932

2.  Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.

Authors:  A Thomas; G L Baillie; A M Phillips; R K Razdan; R A Ross; R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

3.  The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin.

Authors:  Barbara L F Kaplan; Jody E Lawver; Peer W F Karmaus; Thitirat Ngaotepprutaram; Neil P Birmingham; Jack R Harkema; Norbert E Kaminski
Journal:  Toxicol Pathol       Date:  2010-02-26       Impact factor: 1.902

4.  Preservation of eumelanin hair pigmentation in proopiomelanocortin-deficient mice on a nonagouti (a/a) genetic background.

Authors:  Andrzej Slominski; Przemyslaw M Plonka; Alexander Pisarchik; James L Smart; Virginie Tolle; Jacobo Wortsman; Malcolm J Low
Journal:  Endocrinology       Date:  2004-11-24       Impact factor: 4.736

5.  The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects.

Authors:  Lirit N Franks; Benjamin M Ford; Toshifumi Fujiwara; Haibo Zhao; Paul L Prather
Journal:  Toxicol Appl Pharmacol       Date:  2018-06-12       Impact factor: 4.219

6.  Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.

Authors:  Alison E B Springs; Peer W F Karmaus; Robert B Crawford; Barbara L F Kaplan; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2008-09-12       Impact factor: 4.962

7.  Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis.

Authors:  Rodrigo Guabiraba; Remo C Russo; Amanda M Coelho; Mônica A N D Ferreira; Gabriel A O Lopes; Ariane K C Gomes; Silvia P Andrade; Luciola S Barcelos; Mauro M Teixeira
Journal:  Inflamm Res       Date:  2013-05-31       Impact factor: 4.575

8.  AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors.

Authors:  Douglas Thewke; Natalie Freeman-Anderson; Theresa Pickle; Courtney Netherland; Courtney Chilton
Journal:  Biochem Biophys Res Commun       Date:  2009-02-11       Impact factor: 3.575

9.  Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.

Authors:  Ying Pei; Richard W Mercier; Jenine K Anday; Ganesh A Thakur; Alexander M Zvonok; Dow Hurst; Patricia H Reggio; David R Janero; Alexandros Makriyannis
Journal:  Chem Biol       Date:  2008-11-24

10.  Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242.

Authors:  I Mancini; R Brusa; G Quadrato; C Foglia; P Scandroglio; L S Silverman; D Tulshian; A Reggiani; M Beltramo
Journal:  Br J Pharmacol       Date:  2009-06-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.